Le Lézard
Classified in: Health
Subject: SVY

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary



Download the full report: https://www.reportbuyer.com/product/4465333


GlobalData's Medical Devices sector report, "Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017" provides an overview of Synthetic Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Synthetic Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Synthetic Bone Graft Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/4465333

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 20:15
The next frontier is truly the mind. To explore our vast galaxy, one of the most useful avenues has been Virtual Reality (VR). What makes VR so special is its ability to allow you to transport into another world without literally having to move an...

at 16:50
AbbVie , a global research and development-based biopharmaceutical company, today presented new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical trials that evaluated the safety and efficacy of risankizumab (150...

at 16:00
AbbVie , a global research and development-based biopharmaceutical company, today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult...

at 15:00
Evolus, Inc. today announced the presentation of data from the Phase III comparative clinical trial of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at the American Academy of Dermatology (AAD) meeting....

at 11:00
Veterans gathered to bond and learn adaptive winter sports techniques from experienced instructors at the Arizona Snowbowl. During the two-day-adaptive ski and snowboard experience with Wounded Warrior Project® (WWP), some veterans with injuries...

at 08:00
Cardax, Inc. announced today that ZanthoSyn® (60 count), the Company's premium astaxanthin dietary supplement for inflammatory health and longevity, was the top selling product in Hawaii GNC stores for the fourth quarter of 2017, based on...




News published on 6 october 2017 at 09:56 and distributed by: